Corning Inc led the $34 million Series B funding round for Cambridge, Massachusetts-based medical device maker NinePoint Medical Inc, a statement about the funding said.
Igenica Inc, the biopharmaceutical firm dedicated to developing antibodies and antibody-drug conjugates to treat the Big C, obtained $14 million in its Series C extension round.
Cambridge-based anti-obesity drug developer Zafgen Inc bagged another USD45 million in a Series E funding round today, bringing its total funding to date to USD114 million.
A consortium of venture capitalists had helped Editas Medicine raised USD43 million in Series A financing to create medicine designed to eradicate gene abnormalities.
Biopharmaceutical firm SAGE Therapeutics scored USD 20 million from ARCH Venture Partners and Third Rock Ventures in its Series B funding round.
Alcresta announced that it had raised US$10 million to accelerate production and commercialization of its drug that helps cancer patients.
bluebird bio today announced the successful completion of a $60 million Series D financing.